We are live on ! Find out more
WC

Westhampton Capital Portfolio holdings

AUM $241M
1-Year Est. Return 38.64%
This Fund
S&P 500
This Quarter Est. Return
+13.36%
1 Year Est. Return
+38.64%
3 Year Est. Return
+95.59%
5 Year Est. Return
+130.02%
10 Year Est. Return
–
AUM
$134M
AUM Growth
+$11.7M
Cap. Flow
-$2.21M
Cap. Flow %
-1.65%
Top 10 Hldgs %
38.88%
Holding
105
New
3
Increased
24
Reduced
49
Closed
2

Top Buys

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$221K
2
WFC icon
Wells Fargo
WFC
+$217K
3
IBM icon
IBM
IBM
+$210K
4
IBB icon
iShares Biotechnology ETF
IBB
+$191K
5
UL icon
Unilever
UL
+$114K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$471K
2
CVS icon
CVS Health
CVS
+$247K
3
GILD icon
Gilead Sciences
GILD
+$243K
4
PG icon
Procter & Gamble
PG
+$230K
5
FDX icon
FedEx
FDX
+$218K

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.56%
2 Industrials 20.57%
3 Technology 17.93%
4 Consumer Discretionary 8.88%
5 Healthcare 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNB icon
101
FNB Corp
FNB
$6.71B
$99K 0.07%
10,383
– –
PEI
102
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$15K 0.01%
1,000
– –
BMY.RT
103
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$8K 0.01%
11,150
-2,000
-15% -$4.26K
BIIB icon
104
Biogen
BIIB
$29.5B
– –
-1,660
Closed -$471K
FDX icon
105
FedEx
FDX
$73.5B
– –
-867
Closed -$218K
1 2 3 4
5

Similar funds

PFWA
Paces Ferry Wealth Advisors Atlanta, Georgia $241M AUM 17.16% 1-Year Est. Return
SIM
Sherborne Investors Management New York $241M AUM 35.23% 1-Year Est. Return
AA
Altman Advisors Chicago, Illinois $241M AUM 31.3% 1-Year Est. Return
TTA
Thor Trading Advisors Greensburg, Pennsylvania $241M AUM 16.84% 1-Year Est. Return
RS
Rakuten Securities Tokyo, Japan $241M AUM 94.43% 1-Year Est. Return
DCM
Dean Capital Management Overland Park, Kansas $241M AUM 32.7% 1-Year Est. Return
GL
GHE LLC Memphis, Tennessee $241M AUM 34.93% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $242M AUM 35.05% 1-Year Est. Return

Westhampton Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Westhampton Capital held 105 positions worth $134M, up 9.6% from $122M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 4.8%. Westhampton Capital opened 3 new positions and exited 2, leaving the 105-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.

  • Westhampton Capital's largest Q4 2020 buy was TransDigm Group: 402 shares worth $249K.
  • Westhampton Capital added most to IBM in Q4 2020, an estimated $210K increase.
  • Westhampton Capital's biggest Q4 2020 reduction was CVS Health, cutting an estimated $247K.
  • Westhampton Capital fully exited Biogen in Q4 2020, selling an estimated $471K.
  • Westhampton Capital's ten largest holdings make up 39% of its $134M portfolio in Q4 2020.
  • Westhampton Capital opened 3 new positions and closed 2 in Q4 2020.
  • Westhampton Capital's portfolio value rose 9.6% quarter-over-quarter to $134M.

Based on Westhampton Capital's 13F filing for Q4 2020, filed 3 Feb 2021.